Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD) (CHRONOBIO)

April 15, 2024 updated by: Michaël RACODON

Effect of Time of Exercise Re-training on Functional Capacity in Individuals With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary rehabilitation (PR) is an effective intervention for reducing hospital readmissions, secondary events, and mortality in patients with respiratory pathologies.

The program should not be improved by introducing new subjects such as circadian rhythm.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Respiratory diseases are a leading cause of death in developed countries. To avoid complications and recurrences, secondary prevention in patients with respiratory diseases is essential. Pulmonary rehabilitation (PR) is a well-established and effective treatment that is supervised by medical professionals and conducted in dedicated centres. It has been shown to reduce hospital readmissions, secondary events, and patient mortality.

The timing of reconditioning is crucial. Previous studies have indicated that training times affect strength and power gains. Additionally, the time of day for training can significantly impact progress in aerobic capacity.

Disturbances to the biological clock can have consequences for people with respiratory pathologies, particularly an alteration in muscular function.

Therefore, studying the temporal specificity of exercise re-training in patients with respiratory diseases is of interest.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Patient with chronic obstructive pulmonary disease (COPD)
  • Registered for respiratory re-education and rehabilitation at the Clinique de la Mitterie
  • Number of rehabilitation sessions at least 18 over 4 weeks
  • Written informed consent signed by the patient
  • Membership of a social security

Exclusion Criteria:

  • - cardiovascular contraindications to exercise
  • unstable respiratory status (uncompensated respiratory acidosis)
  • conditions interfering with the pulmonary rehabilitation process (progressive neuromuscular disease, psychiatric illness)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Morning group
Endurance and muscular exercise can be performed in the morning, either at 9:00am or 9:45am, or vice versa.

Pulmonary rehabilitation includes :

  • Exercise re-training with resumption of physical activities
  • therapeutic patient education
Other: Afternoon group
Endurance and muscular exercise can be performed in the afternoon, from 3:00 pm to 3:45 pm, or vice versa.

Pulmonary rehabilitation includes :

  • Exercise re-training with resumption of physical activities
  • therapeutic patient education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6-minute walk test (6MWT)
Time Frame: 15 minutes
Walking distance in a test
15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time limit test (Time-lim)
Time Frame: 0 to 900 secondes
Endurance exercise holding time in seconds
0 to 900 secondes
Sit to stand test (STT)
Time Frame: 1 minute
The number of sit-to-stand repetitions during the test.
1 minute
Single arm curl Test (SAC)
Time Frame: 1 minute
The number of bends during the test
1 minute
Single-leg stance test (SLT)
Time Frame: 1 minute
The time for balance
1 minute
Hospital Anxiety and Depression Scale (HAD)
Time Frame: 10 minutes. The maximum mark for each score is 21 and the minimum mark is 0. The higher the score, the more depressed or anxious the person.
Hospital Anxiety and Depression score
10 minutes. The maximum mark for each score is 21 and the minimum mark is 0. The higher the score, the more depressed or anxious the person.
Pittsburgh Sleep Quality Index
Time Frame: 10 minutes. The total score ranges from 0 to 21, with 0 indicating no difficulties and 21 indicating major difficulties.
Sleep quality score
10 minutes. The total score ranges from 0 to 21, with 0 indicating no difficulties and 21 indicating major difficulties.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2024

Primary Completion (Actual)

January 2, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

April 10, 2024

First Submitted That Met QC Criteria

April 10, 2024

First Posted (Actual)

April 15, 2024

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 15, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The IPD sharing plan with other researchers is only available on site at the clinic.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Diseases

Clinical Trials on Pulmonary rehabilitation

3
Subscribe